Patents on Quantitative Susceptibility Mapping (QSM) of Tissue Magnetism.
暂无分享,去创建一个
Feng Lin | Pascal Spincemaille | Yi Wang | Martin R Prince | Yi Wang | M. Prince | P. Spincemaille | Feng Lin
[1] Yi Wang,et al. Improved subthalamic nucleus depiction with quantitative susceptibility mapping. , 2013, Radiology.
[2] Andreas Charidimou,et al. Cerebral microbleeds: a guide to detection and clinical relevance in different disease settings , 2013, Neuroradiology.
[3] John P. Wikswo,et al. Magnetic susceptibility tomography for three-dimensional imaging of diamagnetic and paramagnetic objects , 1994 .
[4] Ferdinand Schweser,et al. Foundations of MRI phase imaging and processing for Quantitative Susceptibility Mapping (QSM). , 2016, Zeitschrift fur medizinische Physik.
[5] Yongquan Ye,et al. Quantifying the changes in oxygen extraction fraction and cerebral activity caused by caffeine and acetazolamide , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[6] Yi Wang,et al. Quantitative s usceptibility Mapping of Multiple s clerosis lesions at Various ages 1 , 2014 .
[7] Gary F. Egan,et al. Improved Quantification of Cerebral Vein Oxygenation Using Partial Volume Correction , 2017, Front. Neurosci..
[8] J. Ford,et al. Brain regions associated with psychological pain: implications for a neural network and its relationship to physical pain , 2012, Brain Imaging and Behavior.
[9] C. Tejos,et al. Fast nonlinear susceptibility inversion with variational regularization , 2018, Magnetic resonance in medicine.
[10] Saifeng Liu,et al. Quantitative susceptibility mapping of small objects using volume constraints , 2013, Magnetic resonance in medicine.
[11] J. Reichenbach,et al. Detection of Cerebral Microbleeds with Quantitative Susceptibility Mapping in the Arcabeta Mouse Model of Cerebral Amyloidosis , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[12] Yang Song,et al. Seed point discontinuity‐based segmentation method for the substantia nigra and the red nucleus in quantitative susceptibility maps , 2018, Journal of magnetic resonance imaging : JMRI.
[13] T. Rouault,et al. Iron metabolism in the CNS: implications for neurodegenerative diseases , 2013, Nature Reviews Neuroscience.
[14] Hongjiang Wei,et al. Quantitative susceptibility mapping as a biomarker for evaluating white matter alterations in Parkinson’s disease , 2018, Brain Imaging and Behavior.
[15] Luca Roccatagliata,et al. Multiple sclerosis: hyperintense dentate nucleus on unenhanced T1-weighted MR images is associated with the secondary progressive subtype. , 2009, Radiology.
[16] Pascal Spincemaille,et al. Nonlinear Regularization for Per Voxel Estimation of Magnetic Susceptibility Distributions From MRI Field Maps , 2010, IEEE Transactions on Medical Imaging.
[17] Xu Li,et al. Mapping magnetic susceptibility anisotropies of white matter in vivo in the human brain at 7T , 2012, NeuroImage.
[18] Simon Hametner,et al. Iron and neurodegeneration in the multiple sclerosis brain , 2013, Annals of neurology.
[19] H. Per,et al. Diagnosis of intracranial calcification and hemorrhage in pediatric patients: Comparison of quantitative susceptibility mapping and phase images of susceptibility-weighted imaging. , 2017, Diagnostic and interventional imaging.
[20] Hongyan Ni,et al. Quantification of liver iron concentration using the apparent susceptibility of hepatic vessels. , 2018, Quantitative imaging in medicine and surgery.
[21] Yi Wang,et al. Background field removal by solving the Laplacian boundary value problem , 2014, NMR in biomedicine.
[22] Torsten Rohlfing,et al. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping , 2011, NeuroImage.
[23] Saifeng Liu,et al. Reduced deep regional cerebral venous oxygen saturation in hemodialysis patients using quantitative susceptibility mapping , 2018, Metabolic Brain Disease.
[24] Yi Wang,et al. Simultaneous Phase Unwrapping and Removal of Chemical Shift (SPURS) Using Graph Cuts: Application in Quantitative Susceptibility Mapping , 2015, IEEE Transactions on Medical Imaging.
[25] Sanjeev Chawla,et al. Longitudinal study of multiple sclerosis lesions using ultra-high field (7T) multiparametric MR imaging , 2018, PloS one.
[26] E. Haacke,et al. Imaging iron stores in the brain using magnetic resonance imaging. , 2005, Magnetic resonance imaging.
[27] Abdulhakim Coskun,et al. Magnetic Susceptibility Changes in the Basal Ganglia and Brain Stem of Patients with Wilson’s Disease: Evaluation with Quantitative Susceptibility Mapping , 2017, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.
[28] Ferdinand Schweser,et al. An illustrated comparison of processing methods for phase MRI and QSM: removal of background field contributions from sources outside the region of interest , 2017, NMR in biomedicine.
[29] A H Wilman,et al. Structural and functional quantitative susceptibility mapping from standard fMRI studies , 2017, NMR in biomedicine.
[30] DuhamelAlain,et al. Targeting chelatable iron as a therapeutic modality in Parkinson's disease. , 2014 .
[31] Jeffrey A. Fessler,et al. Accelerated Regularized Estimation of MR Coil Sensitivities Using Augmented Lagrangian Methods , 2013, IEEE Transactions on Medical Imaging.
[32] Tian Liu,et al. Internal structures of the globus pallidus in patients with Parkinson’s disease: evaluation with quantitative susceptibility mapping (QSM) , 2015, European Radiology.
[33] Yi Wang,et al. Texture analyses of quantitative susceptibility maps to differentiate Alzheimer's disease from cognitive normal and mild cognitive impairment. , 2016, Medical physics.
[34] Min Zhang,et al. Reducing the object orientation dependence of susceptibility effects in gradient echo MRI through quantitative susceptibility mapping , 2012, Magnetic resonance in medicine.
[35] S. Reeder,et al. Quantitative susceptibility mapping in the abdomen as an imaging biomarker of hepatic iron overload , 2015, Magnetic resonance in medicine.
[36] Wei Zhou,et al. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping , 2018, Journal of the Neurological Sciences.
[37] B. Forstmann,et al. A gradual increase of iron toward the medial‐inferior tip of the subthalamic nucleus , 2014, Human brain mapping.
[38] Yi Wang,et al. Visualizing and Quantifying Acute Inflammation Using ICAM-1 Specific Nanoparticles and MRI Quantitative Susceptibility Mapping , 2011, Annals of Biomedical Engineering.
[39] Guy B. Williams,et al. In Vivo Quantitative Susceptibility Mapping (QSM) in Alzheimer's Disease , 2013, PloS one.
[40] Karin Shmueli,et al. Noninvasive quantification of oxygen saturation in the portal and hepatic veins in healthy mice and those with colorectal liver metastases using QSM MRI , 2018, Magnetic resonance in medicine.
[41] Nian Wang,et al. Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping , 2017, NMR in biomedicine.
[42] Xiaoping Hu,et al. Dentate nucleus iron deposition is a potential biomarker for tremor‐dominant Parkinson's disease , 2017, NMR in biomedicine.
[43] M. Moseley,et al. Improved sensitivity to magnetic susceptibility contrast , 1993, Magnetic resonance in medicine.
[44] Jeff H Duyn,et al. Contributions to magnetic susceptibility of brain tissue , 2017, NMR in biomedicine.
[45] Dong Zhou,et al. Magnetic susceptibility anisotropy: Cylindrical symmetry from macroscopically ordered anisotropic molecules and accuracy of MRI measurements using few orientations , 2013, NeuroImage.
[46] Daniel Nanz,et al. Effect of respiratory hyperoxic challenge on magnetic susceptibility in human brain assessed by quantitative susceptibility mapping (QSM) , 2015, NMR in biomedicine.
[47] Johannes Schwarz,et al. Comparison of T2*-weighted and QSM contrasts in Parkinson's disease to visualize the STN with MRI , 2017, PloS one.
[48] Massimo Filippi,et al. Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions. , 2016, The Journal of clinical investigation.
[49] J. Arias,et al. Iron oxide-based multifunctional nanoparticulate systems for biomedical applications: a patent review (2008 – present) , 2015, Expert opinion on therapeutic patents.
[50] Li Guo,et al. Quantitative susceptibility mapping: Report from the 2016 reconstruction challenge , 2017, Magnetic resonance in medicine.
[51] Olivier Salvado,et al. Cerebral quantitative susceptibility mapping predicts amyloid-&bgr;-related cognitive decline , 2017, Brain : a journal of neurology.
[52] P-Y Lin,et al. Quantitative Susceptibility Mapping of Human Brain at 3T: A Multisite Reproducibility Study , 2015, American Journal of Neuroradiology.
[53] Chunlei Liu,et al. Quantitative susceptibility mapping in combination with water-fat separation for simultaneous liver iron and fat fraction quantification , 2018, European Radiology.
[54] Wei Li,et al. Susceptibility‐weighted imaging and quantitative susceptibility mapping in the brain , 2015, Journal of magnetic resonance imaging : JMRI.
[55] Yi Wang,et al. Age and sex related differences in subcortical brain iron concentrations among healthy adults , 2015, NeuroImage.
[56] Ferdinand Schweser,et al. Quantitative Susceptibility Mapping Differentiates between Blood Depositions and Calcifications in Patients with Glioblastoma , 2013, PloS one.
[57] Saifeng Liu,et al. Susceptibility‐weighted imaging: current status and future directions , 2017, NMR in biomedicine.
[58] Hongfu Sun,et al. Quantitative susceptibility mapping using a superposed dipole inversion method: Application to intracranial hemorrhage , 2016, Magnetic resonance in medicine.
[59] J. R. Reichenbach,et al. Quantitative Susceptibility Mapping: Concepts and Applications , 2015, Clinical Neuroradiology.
[60] Pascal Spincemaille,et al. Quantitative susceptibility mapping‐based cerebral metabolic rate of oxygen mapping with minimum local variance , 2018, Magnetic resonance in medicine.
[61] Towfique Raj,et al. 154 Expression Quantitative Trait Locus Analysis From Primary Immune Cells Identifies Novel Regulatory Effects Underlying Intracranial Aneurysms Susceptibility. , 2016, Neurosurgery.
[62] Alexander Radbruch,et al. High-Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted Images: Evaluation of the Macrocyclic Gadolinium-Based Contrast Agent Gadobutrol , 2015, Investigative radiology.
[63] Gregory Simchick,et al. Assessment of MR‐based R2* and quantitative susceptibility mapping for the quantification of liver iron concentration in a mouse model at 7T , 2018, Magnetic resonance in medicine.
[64] Tian Liu,et al. Quantitative susceptibility mapping of the motor cortex in amyotrophic lateral sclerosis and primary lateral sclerosis. , 2015, AJR. American journal of roentgenology.
[65] David Bonekamp,et al. Potential of quantitative susceptibility mapping for detection of prostatic calcifications , 2017, Journal of magnetic resonance imaging : JMRI.
[66] Jyh-Horng Chen,et al. Quantitative Susceptibility Mapping-Based Microscopy of Magnetic Resonance Venography (QSM-mMRV) for In Vivo Morphologically and Functionally Assessing Cerebromicrovasculature in Rat Stroke Model , 2016, PloS one.
[67] Chaewon Shin,et al. Non-Motor Symptom Burdens Are Not Associated with Iron Accumulation in Early Parkinson's Disease: a Quantitative Susceptibility Mapping Study , 2018, Journal of Korean medical science.
[68] Maurizio Melis,et al. A pilot trial of deferiprone for neurodegeneration with brain iron accumulation , 2011, Haematologica.
[69] S. Borins,et al. Encouraging innovation in the public sector , 2001 .
[70] Hongjiang Wei,et al. Quantitative Susceptibility Mapping: Contrast Mechanisms and Clinical Applications , 2015, Tomography.
[71] D. Parker,et al. The Voxel Sensitivity Function in Fourier Transform Imaging: Applications to Magnetic Resonance Angiography , 1995, Magnetic resonance in medicine.
[72] Julie C Stout,et al. Iron accumulation in the basal ganglia in Huntington's disease: cross-sectional data from the IMAGE-HD study , 2015, Journal of Neurology, Neurosurgery & Psychiatry.
[73] Shigeru Furui,et al. Gadolinium Deposition after Contrast-enhanced MR Imaging. , 2015, Radiology.
[74] T. S. St. Pierre,et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. , 2005, Blood.
[75] Robert Zivadinov,et al. Changes of deep gray matter magnetic susceptibility over 2 years in multiple sclerosis and healthy control brain , 2017, NeuroImage: Clinical.
[76] Young-Jun Lee,et al. Quantitative susceptibility mapping of the motor cortex: a comparison of susceptibility among patients with amyotrophic lateral sclerosis, cerebrovascular disease, and healthy controls , 2017, Neuroradiology.
[77] Yi Wang,et al. Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: Interpreting positive susceptibility and the presence of iron , 2015, Magnetic resonance in medicine.
[78] Ferdinand Schweser,et al. Quantitative Susceptibility Mapping in Parkinson's Disease , 2016, PloS one.
[79] E. Haacke,et al. Quantitative susceptibility mapping: current status and future directions. , 2015, Magnetic resonance imaging.
[80] I D Wilkinson,et al. Motion artifacts in standard clinical setting obscure disease-specific differences in quantitative susceptibility mapping , 2018, Physics in medicine and biology.
[81] Ferdinand Schweser,et al. Overview of quantitative susceptibility mapping , 2017, NMR in biomedicine.
[82] Yi Wang,et al. Magnetic source MRI: A new quantitative imaging of magnetic biomarkers , 2009, 2009 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[83] Richard E Thompson,et al. Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage , 2018, Journal of magnetic resonance imaging : JMRI.
[84] Susumu Mori,et al. Human brain atlas for automated region of interest selection in quantitative susceptibility mapping: Application to determine iron content in deep gray matter structures , 2013, NeuroImage.
[85] Saifeng Liu,et al. Iron quantification in Parkinson's disease using an age-based threshold on susceptibility maps: The advantage of local versus entire structure iron content measurements. , 2019, Magnetic resonance imaging.
[86] Lei Wang,et al. Increased Iron Deposition on Brain Quantitative Susceptibility Mapping Correlates with Decreased Cognitive Function in Alzheimer's Disease. , 2018, ACS chemical neuroscience.
[87] Ives R Levesque,et al. Phase processing for quantitative susceptibility mapping of regions with large susceptibility and lack of signal , 2018, Magnetic resonance in medicine.
[88] Yi Wang,et al. A novel background field removal method for MRI using projection onto dipole fields (PDF) , 2011, NMR in biomedicine.
[89] A Federico,et al. Six-year clinical and MRI quantitative susceptibility mapping (QSM) follow-up in neurological Wilson’s disease under zinc therapy: a case report , 2018, Neurological Sciences.
[90] S. Lehéricy,et al. Reproducibility of R2* and quantitative susceptibility mapping (QSM) reconstruction methods in the basal ganglia of healthy subjects , 2017, NMR in biomedicine.
[91] J. Reichenbach,et al. Differentiation between diamagnetic and paramagnetic cerebral lesions based on magnetic susceptibility mapping. , 2010, Medical physics.
[92] Pascal Spincemaille,et al. On the influence of zero-padding on the nonlinear operations in Quantitative Susceptibility Mapping. , 2017, Magnetic resonance imaging.
[93] Frank Tacke,et al. Macrophage heterogeneity in liver injury and fibrosis. , 2014, Journal of hepatology.
[94] José P. Marques,et al. An illustrated comparison of processing methods for MR phase imaging and QSM: combining array coil signals and phase unwrapping , 2016, NMR in biomedicine.
[95] R. Edelman,et al. Joint estimation of chemical shift and quantitative susceptibility mapping (chemical QSM) , 2015, Magnetic resonance in medicine.
[96] Alan H Wilman,et al. Quantitative Susceptibility Mapping for Following Intracranial Hemorrhage. , 2018, Radiology.
[97] Eric Westman,et al. Quantitative susceptibility mapping differentiates between parkinsonian disorders. , 2017, Parkinsonism & related disorders.
[98] E. Purcell,et al. Relaxation Effects in Nuclear Magnetic Resonance Absorption , 1948 .
[99] Won-Jin Moon,et al. Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging. , 2016, Journal of Alzheimer's disease : JAD.
[100] Jin Keun Seo,et al. Quantitative Susceptibility Mapping (QSM) Algorithms: Mathematical Rationale and Computational Implementations , 2017, IEEE Transactions on Biomedical Engineering.
[101] Shuhui Cai,et al. Altered brain iron content and deposition rate in Huntington’s disease as indicated by quantitative susceptibility MRI , 2018, Journal of neuroscience research.
[102] Hisashi Tanaka,et al. Quantifying changes in nigrosomes using quantitative susceptibility mapping and neuromelanin imaging for the diagnosis of early-stage Parkinson's disease. , 2018, The British journal of radiology.
[103] Pascal Spincemaille,et al. Quantitative mapping of cerebral metabolic rate of oxygen (CMRO2) using quantitative susceptibility mapping (QSM) , 2015, Magnetic resonance in medicine.
[104] B. Forstmann,et al. Direct visualization of the subthalamic nucleus and its iron distribution using high‐resolution susceptibility mapping , 2012, Human brain mapping.
[105] Pascal Spincemaille,et al. Cerebral microbleeds: burden assessment by using quantitative susceptibility mapping. , 2012, Radiology.
[106] T. Hirai,et al. Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care , 2017, Journal of magnetic resonance imaging : JMRI.
[107] Takoua Kaaouana,et al. 2D harmonic filtering of MR phase images in multicenter clinical setting: Toward a magnetic signature of cerebral microbleeds , 2015, NeuroImage.
[108] Dosik Hwang,et al. Susceptibility map‐weighted imaging (SMWI) for neuroimaging , 2014, Magnetic resonance in medicine.
[109] Se Young Chun,et al. Specific visualization of neuromelanin-iron complex and ferric iron in the human post-mortem substantia nigra using MR relaxometry at 7T , 2017, NeuroImage.
[110] Yi Wang,et al. Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: Validation and application to brain imaging , 2010, Magnetic resonance in medicine.
[111] Yu-Chung N. Cheng,et al. Susceptibility weighted imaging (SWI) , 2004, Zeitschrift fur medizinische Physik.
[112] Yi Wang,et al. Quantitative susceptibility mapping to evaluate the early stage of Alzheimer's disease☆ , 2017, NeuroImage: Clinical.
[113] Tsutomu Okada,et al. Quantitative Susceptibility Mapping at 3 T and 1.5 T: Evaluation of Consistency and Reproducibility , 2015, Investigative radiology.
[114] Pascal Spincemaille,et al. Nonlinear formulation of the magnetic field to source relationship for robust quantitative susceptibility mapping , 2013, Magnetic resonance in medicine.
[115] Jian-Qiang Lu,et al. Validation of quantitative susceptibility mapping with Perls' iron staining for subcortical gray matter , 2015, NeuroImage.
[116] David Pitt,et al. Significance and In Vivo Detection of Iron-Laden Microglia in White Matter Multiple Sclerosis Lesions , 2018, Front. Immunol..
[117] Tim G St Pierre,et al. Multicenter Validation of Spin-Density Projection-Assisted R2-MRI for the Noninvasive Measurement of Liver Iron Concentration , 2013, Magnetic resonance in medicine.
[118] Yuefeng Li,et al. Quantitative Susceptibility Mapping Reveals an Association between Brain Iron Load and Depression Severity , 2017, Front. Hum. Neurosci..
[119] Hans Lassmann,et al. Progressive multiple sclerosis: pathology and pathogenesis , 2012, Nature Reviews Neurology.
[120] Peter C. M. van Zijl,et al. Simultaneous quantitative susceptibility mapping and Flutemetamol-PET suggests local correlation of iron and β-amyloid as an indicator of cognitive performance at high age , 2018, NeuroImage.
[121] Klaas Paul Pruessmann,et al. Probing neuronal activation by functional quantitative susceptibility mapping under a visual paradigm: A group level comparison with BOLD fMRI and PET , 2016, NeuroImage.
[122] Dana Cobzas,et al. Subcortical gray matter segmentation and voxel‐based analysis using transverse relaxation and quantitative susceptibility mapping with application to multiple sclerosis , 2015, Journal of magnetic resonance imaging : JMRI.
[123] Zhifeng Kou,et al. Decreased oxygen saturation in asymmetrically prominent cortical veins in patients with cerebral ischemic stroke. , 2014, Magnetic resonance imaging.
[124] Jingjing Xu,et al. Influence of regional iron on the motor impairments of Parkinson's disease: A quantitative susceptibility mapping study , 2017, Journal of magnetic resonance imaging : JMRI.
[125] Pascal Spincemaille,et al. Cerebral metabolic rate of oxygen (CMRO2) mapping by combining quantitative susceptibility mapping (QSM) and quantitative blood oxygenation level‐dependent imaging (qBOLD) , 2018, Magnetic resonance in medicine.
[126] Yi Wang,et al. Morphology enabled dipole inversion for quantitative susceptibility mapping using structural consistency between the magnitude image and the susceptibility map , 2012, NeuroImage.
[127] Benjamin Leporq,et al. In vitro distinction between proinflammatory and antiinflammatory macrophages with gadolinium‐liposomes and ultrasmall superparamagnetic iron oxide particles at 3.0T , 2018, Journal of magnetic resonance imaging : JMRI.
[128] Jiwon Oh,et al. Magnetic susceptibility contrast variations in multiple sclerosis lesions , 2016, Journal of magnetic resonance imaging : JMRI.
[129] Pascal Spincemaille,et al. Clinical Integration of Quantitative Susceptibility Mapping Magnetic Resonance Imaging into Neurosurgical Practice. , 2019, World neurosurgery.
[130] Jianrong Xu,et al. Streaking artifact reduction for quantitative susceptibility mapping of sources with large dynamic range , 2015, NMR in biomedicine.
[131] Jun Liu,et al. [Advances in clinical application of quantitative susceptibility mapping in central nervous system]. , 2015, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences.
[132] Yi Wang,et al. Preconditioned total field inversion (TFI) method for quantitative susceptibility mapping , 2017, Magnetic resonance in medicine.
[133] G. Brittenham,et al. Iron-chelating therapy for transfusional iron overload. , 2011, The New England journal of medicine.
[134] E. Haacke,et al. Theory of NMR signal behavior in magnetically inhomogeneous tissues: The static dephasing regime , 1994, Magnetic resonance in medicine.
[135] Jason W Allen,et al. Cerebral MR oximetry during acetazolamide augmentation: Beyond cerebrovascular reactivity in hemodynamic failure , 2018, Journal of magnetic resonance imaging : JMRI.
[136] Edward S. Hui,et al. Quantitative susceptibility mapping as an indicator of subcortical and limbic iron abnormality in Parkinson's disease with dementia , 2018, NeuroImage: Clinical.
[137] R R Edelman,et al. Quantitative Susceptibility Mapping in Cerebral Cavernous Malformations: Clinical Correlations , 2016, American Journal of Neuroradiology.
[138] Pascal Spincemaille,et al. Reproducibility of quantitative susceptibility mapping in the brain at two field strengths from two vendors , 2015, Journal of magnetic resonance imaging : JMRI.
[139] Yan Zhang,et al. Utilization of Quantitative Susceptibility Mapping for Direct Targeting of the Subthalamic Nucleus During Deep Brain Stimulation Surgery. , 2018, Operative neurosurgery.
[140] Yi Wang,et al. Cardiac quantitative susceptibility mapping (QSM) for heart chamber oxygenation , 2018, Magnetic resonance in medicine.
[141] Kawin Setsompop,et al. Quantitative susceptibility mapping using deep neural network: QSMnet , 2018, NeuroImage.
[142] Margit Jehna,et al. Quantitative susceptibility mapping in multiple sclerosis. , 2013, Radiology.
[143] Yan-Qiu Feng,et al. [Quantitative magnetic resonance imaging of brain iron deposition: comparison between quantitative susceptibility mapping and transverse relaxation rate (R2*) mapping]. , 2018, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.
[144] Kenji Ito,et al. Noninvasive Assessment of Oxygen Extraction Fraction in Chronic Ischemia Using Quantitative Susceptibility Mapping at 7 Tesla , 2017, Stroke.
[145] Siegfried Trattnig,et al. Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging , 2016, Acta Neuropathologica.
[146] Tian Liu,et al. Intracranial calcifications and hemorrhages: characterization with quantitative susceptibility mapping. , 2013, Radiology.
[147] Saifeng Liu,et al. Decreased susceptibility of major veins in mild traumatic brain injury is correlated with post-concussive symptoms: A quantitative susceptibility mapping study , 2017, NeuroImage: Clinical.
[148] Hans-Jochen Heinze,et al. Quantitative Susceptibility MRI to Detect Brain Iron in Amyotrophic Lateral Sclerosis. , 2018, Radiology.
[149] Ferdinand Schweser,et al. Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: An approach to in vivo brain iron metabolism? , 2011, NeuroImage.
[150] Eung Yeop Kim,et al. Diagnosis of Early-Stage Idiopathic Parkinson's Disease Using High-Resolution Quantitative Susceptibility Mapping Combined with Histogram Analysis in the Substantia Nigra at 3 T , 2017, Journal of clinical neurology.
[151] O. Johnell,et al. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures , 1996 .
[152] Jiang Du,et al. Bone quantitative susceptibility mapping using a chemical species–specific R2* signal model with ultrashort and conventional echo data , 2018, Magnetic resonance in medicine.
[153] Tom Goldstein,et al. The Split Bregman Method for L1-Regularized Problems , 2009, SIAM J. Imaging Sci..
[154] Bing Wu,et al. Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition , 2011, NeuroImage.
[155] Pascal Spincemaille,et al. In vivo quantification of contrast agent concentration using the induced magnetic field for time-resolved arterial input function measurement with MRI. , 2008, Medical physics.
[156] D. Dexter,et al. Neurodegenerative diseases and therapeutic strategies using iron chelators. , 2015, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.
[157] Tian Liu,et al. Improved Detection of Cortical Gray Matter Involvement in Multiple Sclerosis with Quantitative Susceptibility Mapping. , 2015, Academic radiology.
[158] Dmitriy A. Yablonskiy,et al. Effects of biological tissue structural anisotropy and anisotropy of magnetic susceptibility on the gradient echo MRI signal phase: theoretical background , 2017, NMR in biomedicine.
[159] Robert Turner,et al. Toward in vivo histology: A comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2 ⁎-imaging at ultra-high magnetic field strength , 2013, NeuroImage.
[160] Robert Turner,et al. Seven-Tesla Magnetic Resonance Imaging in Wilson Disease Using Quantitative Susceptibility Mapping for Measurement of Copper Accumulation , 2014, Investigative radiology.
[161] Tian Liu,et al. Dynamic Permeability and Quantitative Susceptibility: Related Imaging Biomarkers in Cerebral Cavernous Malformations , 2014, Stroke.
[162] Pascal Spincemaille,et al. Cerebral metabolic rate of oxygen (CMRO2) mapping with hyperventilation challenge using quantitative susceptibility mapping (QSM) , 2017, Magnetic resonance in medicine.
[163] Joanes Grandjean,et al. Longitudinal Assessment of Amyloid Pathology in Transgenic ArcAβ Mice Using Multi-Parametric Magnetic Resonance Imaging , 2013, PloS one.
[164] Robert Zivadinov,et al. Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals , 2017, NeuroImage: Clinical.
[165] D. Tank,et al. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[166] David Pines,et al. Relaxation Times in Magnetic Resonance , 1955 .
[167] Richard C. Semelka,et al. High Signal Intensity in Globus Pallidus and Dentate Nucleus on Unenhanced T1-weighted MR Images: Evaluation of Two Linear Gadolinium-based Contrast Agents. , 2015, Radiology.
[168] C. Lind,et al. Magnetic resonance imaging of the subthalamic nucleus for deep brain stimulation. , 2016, Journal of neurosurgery.
[169] Susan A. Gauthier,et al. Diagnostic accuracy of semiautomatic lesion detection plus quantitative susceptibility mapping in the identification of new and enhancing multiple sclerosis lesions , 2018, NeuroImage: Clinical.
[170] Pasquale Borrelli,et al. In vivo dentate nucleus MRI relaxometry correlates with previous administration of Gadolinium-based contrast agents , 2016, European Radiology.
[171] Olaf Dössel,et al. Determination of Electric Conductivity and Local SAR Via B1 Mapping , 2009, IEEE Transactions on Medical Imaging.
[172] G. Brittenham,et al. Iron-chelating therapy and the treatment of thalassemia. , 1997, Blood.
[173] Wei Li,et al. Susceptibility tensor imaging (STI) of the brain , 2017, NMR in biomedicine.
[174] William M. Wells,et al. Quantitative Susceptibility Mapping by Inversion of a Perturbation Field Model: Correlation With Brain Iron in Normal Aging , 2014, IEEE Transactions on Medical Imaging.
[175] Shuai Wang,et al. Noise Effects in Various Quantitative Susceptibility Mapping Methods , 2013, IEEE Transactions on Biomedical Engineering.
[176] Daniel Rueckert,et al. A Deep Cascade of Convolutional Neural Networks for Dynamic MR Image Reconstruction , 2017, IEEE Transactions on Medical Imaging.
[177] Yi Wang,et al. MEDI+0: Morphology enabled dipole inversion with automatic uniform cerebrospinal fluid zero reference for quantitative susceptibility mapping , 2018, Magnetic resonance in medicine.
[178] Leonie Lampe,et al. Baseline oxygenation in the brain: Correlation between respiratory-calibration and susceptibility methods , 2016, NeuroImage.
[179] J. Duyn,et al. Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data , 2009, Magnetic resonance in medicine.
[180] Felix W. Wehrli,et al. Susceptibility‐based time‐resolved whole‐organ and regional tissue oximetry , 2017, NMR in biomedicine.
[181] Peng Lei,et al. Nigral Iron Elevation Is an Invariable Feature of Parkinson's Disease and Is a Sufficient Cause of Neurodegeneration , 2014, BioMed research international.
[182] S. Ogawa. Brain magnetic resonance imaging with contrast-dependent oxygenation , 1990 .
[183] Richard Bowtell,et al. A comparison of phase imaging and quantitative susceptibility mapping in the imaging of multiple sclerosis lesions at ultrahigh field , 2016, Magnetic Resonance Materials in Physics, Biology and Medicine.
[184] Steffen Bollmann,et al. DeepQSM - Using Deep Learning to Solve the Dipole Inversion for MRI Susceptibility Mapping , 2018, bioRxiv.
[185] Yi Wang,et al. High-resolution QSM for functional and structural depiction of subthalamic nuclei in DBS presurgical mapping. , 2019, Journal of neurosurgery.
[186] J. Connor,et al. Iron, brain ageing and neurodegenerative disorders , 2004, Nature Reviews Neuroscience.
[187] David Pitt,et al. Iron Is a Sensitive Biomarker for Inflammation in Multiple Sclerosis Lesions , 2013, PloS one.
[188] David F Kallmes,et al. Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging. , 2015, Radiology.
[189] Li-Wei Kuo,et al. Investigating hyperoxic effects in the rat brain using quantitative susceptibility mapping based on MRI phase , 2017, Magnetic resonance in medicine.
[190] Pascal Spincemaille,et al. Quantitative susceptibility mapping across two clinical field strengths: Contrast‐to‐noise ratio enhancement at 1.5T , 2018, Journal of magnetic resonance imaging : JMRI.
[191] Pascal Spincemaille,et al. Magnetic susceptibility increases as diamagnetic molecules breakdown: Myelin digestion during multiple sclerosis lesion formation contributes to increase on QSM , 2018, Journal of magnetic resonance imaging : JMRI.
[192] Yi Wang,et al. Evaluation of oxygen extraction fraction in systemic lupus erythematosus patients using quantitative susceptibility mapping , 2019, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[193] Dong-Hyun Kim,et al. Imaging of nigrosome 1 in substantia nigra at 3T using multiecho susceptibility map‐weighted imaging (SMWI) , 2017, Journal of magnetic resonance imaging : JMRI.
[194] Y Wang,et al. The Use of Noncontrast Quantitative MRI to Detect Gadolinium-Enhancing Multiple Sclerosis Brain Lesions: A Systematic Review and Meta-Analysis , 2017, American Journal of Neuroradiology.
[195] Y Wang,et al. Combining Quantitative Susceptibility Mapping with Automatic Zero Reference (QSM0) and Myelin Water Fraction Imaging to Quantify Iron-Related Myelin Damage in Chronic Active MS Lesions , 2017, American Journal of Neuroradiology.
[196] C. Robic,et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. , 2008, Chemical reviews.
[197] Yi Wang,et al. Multiple sclerosis lesion geometry in quantitative susceptibility mapping (QSM) and phase imaging , 2015, Journal of magnetic resonance imaging : JMRI.
[198] Emily C. Collins,et al. Tissue magnetic susceptibility mapping as a marker of tau pathology in Alzheimer's disease , 2017, NeuroImage.
[199] Ahmed El-Henawy,et al. A comparative Analytical Studies onAcaciapolyacantha gum Samples collected from three different locations in Sudan , 2014 .
[200] Yi Wang,et al. The clinical utility of QSM: disease diagnosis, medical management, and surgical planning , 2017, NMR in biomedicine.
[201] B. Rosen,et al. Perfusion imaging with NMR contrast agents , 1990, Magnetic resonance in medicine.
[202] Himanshu Bhat,et al. Quantitative oxygenation venography from MRI phase , 2014, Magnetic resonance in medicine.
[203] B. Caffo,et al. Lesion Heterogeneity on High-Field Susceptibility MRI Is Associated with Multiple Sclerosis Severity , 2016, American Journal of Neuroradiology.
[204] Wei Li,et al. 3D fiber tractography with susceptibility tensor imaging , 2012, NeuroImage.
[205] Guang Yang,et al. Quantitative susceptibility mapping (QSM) minimizes interference from cellular pathology in R2* estimation of liver iron concentration , 2018, Journal of magnetic resonance imaging : JMRI.
[206] A. Benabid,et al. Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease , 2009, The Lancet Neurology.
[207] Martin R Prince,et al. Extent of Signal Hyperintensity on Unenhanced T1-weighted Brain MR Images after More than 35 Administrations of Linear Gadolinium-based Contrast Agents. , 2017, Radiology.
[208] Michael A. Saunders,et al. LSQR: An Algorithm for Sparse Linear Equations and Sparse Least Squares , 1982, TOMS.
[209] Hakan Gumus,et al. Brain susceptibility changes in neurologically asymptomatic pediatric patients with Wilson’s disease: evaluation with quantitative susceptibility mapping , 2018, Acta radiologica.
[210] Xavier Golay,et al. Cause and prevention of demyelination in a model multiple sclerosis lesion , 2016, Annals of neurology.
[211] Yi Wang,et al. Diffusion tensor imaging and quantitative susceptibility mapping as diagnostic tools for motor neuron disorders. , 2019, Clinical imaging.
[212] Jon Thacker,et al. Evaluation of Iron Content in Human Cerebral Cavernous Malformation Using Quantitative Susceptibility Mapping , 2014, Investigative radiology.
[213] A. F. Gietl,et al. Colocalization of cerebral iron with Amyloid beta in Mild Cognitive Impairment , 2016, Scientific Reports.
[214] Pascal Spincemaille,et al. Flow compensated quantitative susceptibility mapping for venous oxygenation imaging , 2014, Magnetic resonance in medicine.
[215] Yi Wang,et al. Quantitative MR susceptibility mapping using piece‐wise constant regularized inversion of the magnetic field , 2008, Magnetic resonance in medicine.
[216] Jin Keun Seo,et al. Inverse Problem in Quantitative Susceptibility Mapping , 2012, SIAM J. Imaging Sci..
[217] Lawrence L. Wald,et al. Fast quantitative susceptibility mapping with L1‐regularization and automatic parameter selection , 2013, Magnetic resonance in medicine.
[218] David Kuttenkeuler,et al. Intellectual property rights derived from academic research and their role in the modern bioeconomy-A guide for scientists. , 2018, New biotechnology.
[219] M. Tosetti,et al. Magnetic susceptibility in the deep layers of the primary motor cortex in Amyotrophic Lateral Sclerosis , 2016, NeuroImage: Clinical.
[220] Ashley I Bush,et al. Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics , 2016, Journal of neurochemistry.
[221] Hongjiang Wei,et al. Longitudinal data for magnetic susceptibility of normative human brain development and aging over the lifespan , 2018, Data in brief.
[222] Masako Kinoshita,et al. Increased Signal Intensity in the Dentate Nucleus of Patients with Multiple Sclerosis in Comparison with Neuromyelitis Optica Spectrum Disorder after Multiple Doses of Gadolinium Contrast , 2016, European Neurology.
[223] Robert Zivadinov,et al. Brain Iron at Quantitative MRI Is Associated with Disability in Multiple Sclerosis. , 2018, Radiology.
[224] Yan Zhang,et al. Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM) , 2016, Journal of magnetic resonance imaging : JMRI.
[225] Huan Tan,et al. Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations. , 2017, Journal of neurosurgery.
[226] John S Leigh,et al. Quantifying arbitrary magnetic susceptibility distributions with MR , 2004, Magnetic resonance in medicine.
[227] Robert Turner,et al. Quantitative Susceptibility Mapping of Amyloid-β Aggregates in Alzheimer's Disease with 7T MR. , 2018, Journal of Alzheimer's disease : JAD.
[228] Kemin Chen,et al. Region‐specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping , 2015, Human brain mapping.
[229] Y Wang,et al. Magnetic Susceptibility from Quantitative Susceptibility Mapping Can Differentiate New Enhancing from Nonenhancing Multiple Sclerosis Lesions without Gadolinium Injection , 2016, American Journal of Neuroradiology.
[230] E Mark Haacke,et al. Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2. , 2015, Magnetic resonance imaging.
[231] Anthony Traboulsee,et al. Susceptibility‐sensitive MRI of multiple sclerosis lesions and the impact of normal‐appearing white matter changes , 2017, NMR in biomedicine.
[232] A. Colaianni,et al. Columbia University's Axel patents: technology transfer and implications for the Bayh-Dole Act. , 2009, The Milbank quarterly.
[233] Wei Liu,et al. Imaging Cerebral Microhemorrhages in Military Service Members with Chronic Traumatic Brain Injury. , 2016, Radiology.
[234] G. Adam,et al. MRI‐based quantitative susceptibility mapping (QSM) and R2* mapping of liver iron overload: Comparison with SQUID‐based biomagnetic liver susceptometry , 2017, Magnetic resonance in medicine.
[235] Ajay Kumar Gupta,et al. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. , 2005, Biomaterials.
[236] Yi Wang,et al. Iron in Multiple Sclerosis and Its Noninvasive Imaging with Quantitative Susceptibility Mapping , 2016, International journal of molecular sciences.
[237] Bruce R. Rosen,et al. Regional quantification of cerebral venous oxygenation from MRI susceptibility during hypercapnia , 2015, NeuroImage.
[238] Christian Langkammer,et al. Iron quantification with susceptibility , 2017, NMR in biomedicine.
[239] Yasuo Terayama,et al. Differential diagnosis of parkinsonism by a combined use of diffusion kurtosis imaging and quantitative susceptibility mapping , 2017, Neuroradiology.
[240] Robert Zivadinov,et al. Mapping of thalamic magnetic susceptibility in multiple sclerosis indicates decreasing iron with disease duration: A proposed mechanistic relationship between inflammation and oligodendrocyte vitality , 2018, NeuroImage.
[241] Yi Wang,et al. Calculation of susceptibility through multiple orientation sampling (COSMOS): A method for conditioning the inverse problem from measured magnetic field map to susceptibility source image in MRI , 2009, Magnetic resonance in medicine.
[242] Min Lou,et al. Hematoma Volume Measurement in Gradient Echo MRI Using Quantitative Susceptibility Mapping , 2013, Stroke.
[243] A Makinson,et al. Use of quantitative susceptibility mapping (QSM) in progressive multifocal leukoencephalopathy. , 2016, Journal of neuroradiology. Journal de neuroradiologie.
[244] Tian Liu,et al. Oxygen extraction fraction measurement using quantitative susceptibility mapping: Comparison with positron emission tomography , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[245] Klaus Scheffler,et al. Functional quantitative susceptibility mapping (fQSM) , 2012, NeuroImage.
[246] Pasquale Borrelli,et al. Brain Susceptibility Changes in a Patient with Natalizumab-Related Progressive Multifocal Leukoencephalopathy: A Longitudinal Quantitative Susceptibility Mapping and Relaxometry Study , 2017, Front. Neurol..
[247] Tian Liu,et al. Quantitative Susceptibility Mapping of Intracerebral Hemorrhages at Various Stages , 2016, Journal of magnetic resonance imaging : JMRI.
[248] R. Bowtell,et al. Susceptibility mapping in the human brain using threshold‐based k‐space division , 2010, Magnetic resonance in medicine.
[249] Yi Wang,et al. Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker , 2014, Magnetic resonance in medicine.